| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/26/2003 | CN1398884A Bioactive peptide No.30 |
| 02/26/2003 | CN1398883A Bioactive peptide No.24 |
| 02/26/2003 | CN1398882A Bioactive peptide No.21 |
| 02/26/2003 | CN1398881A Bioactive peptide No.23 |
| 02/26/2003 | CN1398880A Bioactive peptide No.22 |
| 02/26/2003 | CN1398879A Bioactive peptide No.14 |
| 02/26/2003 | CN1398878A Bioactive peptide No.16 |
| 02/26/2003 | CN1398877A Bioactive peptide No.15 |
| 02/26/2003 | CN1398875A Peptide preparing process |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525076 Selective factor Xa inhibitors |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6525026 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/25/2003 | US6524583 Inhibit angiogenesis and induce tumor regression, and have improved safety due to their specificity |
| 02/25/2003 | US6524553 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/20/2003 | WO2003014698A2 Biological assay detection method |
| 02/20/2003 | WO2003014076A2 Bi-directional synthesis of oligoguanidine transport agents |
| 02/20/2003 | WO2003014069A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 02/20/2003 | WO2003013571A1 Peptidomimetics of biologically active metallopeptides |
| 02/20/2003 | WO2002042295A3 Peptides as met-ap2 inhibitors |
| 02/20/2003 | CA2462200A1 Peptidomimetics of biologically active metallopeptides |
| 02/20/2003 | CA2456590A1 Biological assay detection method |
| 02/20/2003 | CA2455951A1 Bi-directional synthesis of oligoguanidine transport agents |
| 02/20/2003 | CA2453245A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283715A1 Modulaton of alpha-6 integrin-mediated responses |
| 02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/19/2003 | CN1398298A Non-endogenous, constitutively activated human G protein-coupled receptors |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/18/2003 | US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521252 Comprises one or several disulphide bonds; cationic lipid type |
| 02/18/2003 | CA2061382C Method for producing cysteine-free peptide |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003011896A1 Peptides having antiangiogenic activity |
| 02/13/2003 | WO2003011115A2 Peptide-based multimeric targeted contrast agents |
| 02/13/2003 | WO2002062810A3 Linkable sialyl lewis x analogs |
| 02/13/2003 | US20030032842 Novel arylpropyl aldehyde derivatives, processes for producing the same, and methods of using the same |
| 02/13/2003 | US20030032774 Novel opioid peptides for the treatment of pain |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032594 Intracellular delivery of biological effectors |
| 02/13/2003 | CA2455638A1 Peptide-based multimeric targeted contrast agents |
| 02/13/2003 | CA2454753A1 Peptides having antiangiogenic activity |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/12/2003 | EP1283213A1 Process for producing aspartyl dipeptide ester derivatives |
| 02/12/2003 | EP1283197A1 Process for producing cinnamylaldehyde derivatives, use thereof and the like |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | CN1396928A Process for preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/11/2003 | US6518436 Process for preparing pharmacologically acceptable salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-amino acid |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518013 Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission |
| 02/11/2003 | CA2109516C Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 02/06/2003 | WO2003010307A1 Peptide synthase gene, peptide synthase and process for producing dipeptide |
| 02/06/2003 | WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | WO2003010189A1 Process for producing dipeptide, peptide synthase to be used therein and process for producing peptide synthase |
| 02/06/2003 | WO2003010187A1 Process for producing dipeptide, l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase |
| 02/06/2003 | WO2003010142A2 A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5 -dioxo-oxazolidine intermediate compounds |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002055543A3 Hybrid peptides for treatment of bacteremia and septicemia |
| 02/06/2003 | WO2002032291A3 Imaging of enzymatic activity |
| 02/06/2003 | WO2002020722A3 Methods and compositions for in vitro targeting |
| 02/06/2003 | WO2001085930A9 Methods and compounds for modulating melanocortin receptor ligand binding and activity |
| 02/06/2003 | US20030027980 Process for preparing lipid ii |
| 02/06/2003 | US20030027850 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2003 | US20030027819 Administering to an animal in need for protease inhibition an effective amount of substituted heterobicyclic compound containing amino acid side chains |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | US20030027771 For therapy of inflammatory condition is selected from asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, tissue transplantation, tumor metastasis |
| 02/06/2003 | US20030027769 For inhibiting angiogenesis |
| 02/06/2003 | US20030027761 For enhancing drug delivery; wound healing; adhesion of foreign tissue implanted within a mammal; inducing apoptosis in a JAM-expressing cell |
| 02/06/2003 | US20030027743 Tripeptidylpeptidase inhibitors |
| 02/06/2003 | CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280919A2 Lipolytic enzyme variants |
| 02/05/2003 | EP1280818A2 Synthesis of n- [n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester using l-alpha-aspartyl-l-phenylalanine 1-methyl ester precursors |
| 02/05/2003 | EP1280817A2 Production and use of protein variants having modified immunogenecity |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | CN1395551A Novel arylpropionaldehyde derivatives and production and use of the same |
| 02/05/2003 | CN1100786C Novel aspartyl dipeptide amide derivatives and sweeteners |
| 02/05/2003 | CN1100785C 1,3,4,5-tetrahydrobenzo [c] azepin-3-one disulfide derivative and method |
| 02/05/2003 | CN1100767C Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515170 Enzymatic oxidative deamination process |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6514978 Compounds such as 1-(n-(2-(amidinoaminooxy)ethyl)amino) carbonylmethyl-6-methyl-3-(phenethylamino)-pyrazinone attached to a polymer coated onto a medical device for blood collection or storage; antiagglomerants |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514759 Isolating a conditioned medium containing a peptide of given formula from a liliaceous plant; use in promoting cell growth of asparagus, rice and maize |
| 02/04/2003 | CA2171953C Modified truncated complement system regulators |
| 01/30/2003 | WO2003008438A2 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 01/30/2003 | WO2003008380A1 Carboxylic acid derivatives |
| 01/30/2003 | WO2003008378A1 Dolastatin 10 derivatives |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003007689A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |